ScottHDonaldsonMD
Pulmonology • Chapel Hill, NCCystic Fibrosis
Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Donaldson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Meadowmont Village Cir
Suite 204; UNC Marsico Clinical Research Center
Chapel Hill, NC 27517Phone+1 984-974-9198
Education & Training
University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1998
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1990 - 1993
University of Michigan Medical SchoolClass of 1990
Certifications & Licensure
NC State Medical License 1993 - 2025
VT State Medical License 1992 - 1994- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis Start of enrollment: 2001 Jul 01
- Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease Start of enrollment: 2008 Oct 01
- Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 130 citationsClinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.David P. Nichols, Alex C Paynter, Sonya L. Heltshe, Scott H. Donaldson, Carla A. Frederick
American Journal of Respiratory and Critical Care Medicine. 2021-11-16 - 377 citationsClinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic FibrosisSteven M. Rowe, Sonya L. Heltshe, Tanja Gonska, Scott H. Donaldson, Drucy Borowitz
American Journal of Respiratory and Critical Care Medicine. 2014-07-15 - 6 citationsEffect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis.Scott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, Peter Mogayzel, Beth L Laube
Journal of Cystic Fibrosis. 2024-01-01
Journal Articles
- SPLUNC1 Degradation by the Cystic Fibrosis Mucosal Environment Drives Airway Surface Liquid DehydrationScott Donaldson, MD, The European Respiratory Journal
Grant Support
- Mucus Dehydration And Evolution Of CF Lung DiseaseNational Heart, Lung, And Blood Institute2006–2010
- Mucus Clearance During Acute Exacerbations Of Cystic FibrosisNational Center For Research Resources2008
- Comprehensive Analysis Of Malnutrition In Adults With Cystic FibrosisNational Center For Research Resources2004–2006
- Regulation Of ENAC By Serine Proteases In AirwaysNational Heart, Lung, And Blood Institute2002–2006
- Oral Spi-8811 In Patients With Cystic FibrosisNational Center For Research Resources2004–2005
- Efficacy Of Amiloride And Hypertonic Saline In Cystic FibrosisNational Center For Research Resources2004–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
